Adams Laboratories   Report issue

For profit Phase 2
Founded: Sacramento CA United States (1985)
Status: Acquired by Medeva (1991) → now UCB (2004)

Organization Overview

First Clinical Trial
1999
NCT00000752
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infections (Phase 2)

Sinusitis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 4